Oncternal Therapeutics Inc
(ONCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 2,521 | 0 | 0 | 0 | 0 |
| Gross Profit | 2,521 | N/A | N/A | N/A | N/A |
| Operating Expenses | 10,107 | 30,655 | 25,933 | 21,841 | 30,348 |
| Operating Income | -7,586 | -30,655 | -25,933 | -21,841 | -30,348 |
| Interest Expense | 1 | 0 | 0 | 0 | 0 |
| Other Income | 1,008 | 216 | 8,209 | 3,138 | -9,063 |
| Pre-tax Income | -6,579 | -30,439 | -17,724 | -18,703 | -39,411 |
| Net Income Continuous | -6,579 | -30,439 | -17,724 | -18,703 | -39,411 |
| Net Income | $-6,579 | $-30,439 | $-17,724 | $-18,703 | $-39,411 |
| EPS Basic Total Ops | -36.60 | -244.93 | -170.75 | -186.14 | -674.60 |
| EPS Basic Continuous Ops | -36.64 | -244.26 | -170.37 | -186.49 | -674.23 |
| EPS Diluted Total Ops | -36.60 | -244.93 | -170.75 | -205.74 | -674.60 |
| EPS Diluted Continuous Ops | -36.64 | -244.26 | -170.37 | -177.14 | -674.23 |
| EPS Diluted Before Non-Recurring Items | -230.93 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-7,586 | $-30,608 | $-25,905 | $-21,798 | $-30,246 |